Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
08037 CH BIOTECH SER
RT Nominal down0.610 -0.005 (-0.813%)
Latest  |  Final  |  Interim
Non-current Assets
2026/06 - Interim
HKD(K$)
%Chg
(Compare to Final)
2025/12
HKD(K$)
2024/12
HKD(K$)
2023/12
HKD(K$)
2022/12
HKD(K$)
Investment Properties0--0000
Property, plant, equip. & others420,0819.194%384,711219,341100,53596,073
Land & other Lease Assets16,172-6.157%17,23315,99623,68032,782
Intangible Assets144,2142.569%140,602138,838164,825177,396
Interests in Asso. & JCEs0--00016,220
Other Non-current Assets77,374-3.692%80,34092,685112,156263,263

657,8415.612%622,886466,860401,196585,734
Current Assets
2026/06 - Interim
HKD(K$)
%Chg
(Compare to Final)
2025/12
HKD(K$)
2024/12
HKD(K$)
2023/12
HKD(K$)
2022/12
HKD(K$)
Inventories56,34952.546%36,9393,9719,27418,725
Trade Receivables1,862-66.857%5,6187,03319,764751,899
Cash & Bank Balances47,147290.193%12,08318,91372,08792,770
Other Current Assets42,43169.392%25,04933,178160,04121,363
Assets Held for Sale9,258--0000

157,04797.075%79,68963,095261,166884,757
Current Liabilities
2026/06 - Interim
HKD(K$)
%Chg
(Compare to Final)
2025/12
HKD(K$)
2024/12
HKD(K$)
2023/12
HKD(K$)
2022/12
HKD(K$)
Trade Payables9,900-70.627%33,7047,3535,787206,441
S-T Debt & Leases121,724-50.750%247,157144,40494,66916,621
Other Current Liabilities27,328-57.890%64,89740,85759,011325,602
Liab asso w/ Assets Held for Sale14,219--0000

173,171-49.916%345,758192,614159,467548,664
Net Current Assets(16,124)-93.940%(266,069)(129,519)101,699336,093
Total Assets Less Current Liabilities641,71779.845%356,817337,341502,895921,827
Non-current Liabilities
2026/06 - Interim
HKD(K$)
%Chg
(Compare to Final)
2025/12
HKD(K$)
2024/12
HKD(K$)
2023/12
HKD(K$)
2022/12
HKD(K$)
L-T Debt & Leases340,158130.236%147,74343,4285,72765,163
Other Non-current Liabilities113,262112.384%53,32951,5256,44230,144

453,420125.501%201,07294,95312,16995,307
Capital and Reserves
2026/06 - Interim
HKD(K$)
%Chg
(Compare to Final)
2025/12
HKD(K$)
2024/12
HKD(K$)
2023/12
HKD(K$)
2022/12
HKD(K$)
  Share Capital97,5730.000%97,57397,57396,32396,323
  Reserves118,78326.584%93,837167,369366,431506,352
  Others0--0000
Shareholders' Funds216,35613.033%191,410264,942462,754602,675
Non-controlling Interests(28,059)-21.326%(35,665)(22,554)27,972223,845
Others0--0000

188,29720.901%155,745242,388490,726826,520
Commitments and Contingent Liabilities
2026/06 - Interim
HKD(K$)
%Chg
(Compare to Final)
2025/12
HKD(K$)
2024/12
HKD(K$)
2023/12
HKD(K$)
2022/12
HKD(K$)
Commitments------122,636208,374238,733
Contingent Liabilities------000
Remarks:  Real time quote last updated: 11/09/2026 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K$)HKD 18,230
%Change--
EPS / (LPS)HKD 0.019
NBV Per Share ($)HKD 0.222
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2026 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.